First person gets new experimental vaccine for Ebola

• A new experimental Ebola vaccine has entered human trials, with a UK volunteer as the first recipient, representing progress toward preventing this high-mortality infection
• The vaccine development has been accelerated in response to the ongoing Ebola outbreak in the Democratic Republic of Congo
• Clinical practitioners should remain alert for updates on this vaccine's efficacy and safety data as trials progress, which may inform future outbreak response protocols

Ed Hunt, 37 and from the UK, voluteered after seeing news reports of the deadly Ebola outbreak in DR Congo.

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.